The Roslin Institute
Roslin Logo

Menu

Roslin in Scots link-up with China to boost genetic research

Research in the growing field of genomics, which could lead to a new generation of personalised medical treatments, will be boosted by an initiative that brings together scientific expertise from China and Edinburgh.

Roslin in Scots link-up with China to boost genetic research

A memorandum of understanding signed between the University of Edinburgh and BGI, the world's largest genomics organisation, will aim to build on both institutions' strengths in genomics.

It will aim to enhance researchers' scientific understanding of the building blocks with which people and other living organisms are made.

The partnership will lead to an expansion of genomics research in Edinburgh, including analysing hereditary information encoded in our DNA, which could help assess risks for particular diseases.

It comes at a time of increasing interest in how better understanding of genes, through DNA sequencing facilities, will help to develop personalised medicines.

Genomics also plays an important role in looking at how livestock can be bred with resistance to diseases to help produce food sustainably for a growing global population.

The agreement between the University of Edinburgh and BGI will explore how research at three genomics facilities in Edinburgh - GenePool Genomics Facility in the School of Biological Sciences, ARK Genomics at the Roslin Institute and the Genetics Core at the Wellcome Trust Clinical Research Facility and the Institute of Genetics and Molecular Medicine - could be enhanced through collaboration with BGI.

As one of the world's largest genomics organisations, BGI has developed an integrative structure of research innovation, platform development and industrial application. BGI is actively building links with research leaders all over the world, with the aim of promoting the advancement of innovative biology research, molecular breeding, healthcare and related fields. Quotes:

This is a fantastic opportunity. Edinburgh is already a hotbed of expertise in genomics and DNA sequencing, and a partnership with BGI would allow us to expand our work into clinical research and, ultimately, personalised genomics.

Professor Mark BlaxterDirector of the School of Biological Science's GenePool Facility

 

Bioinformatics is a key part of the new science: the impact of genomics is limited by our ability to analyse the data, so the concept of combining our existing bioinformatics expertise with that of BGI is very exciting.

Mick WatsonDirector of The Roslin Institute's ARK Genomics facility

 

Livestock genetic improvement is a key part of our response to the challenge of food security, and sequencing and informatics are crucial to future progress. This initiative will underpin Scotland's world-leading research in animal sciences.

Professor David HumeThe Director of the The Roslin Institute

 

The timing is perfect. This opportunity will keep Edinburgh and Scotland at the very leading edge of all aspects of medical genomics, from rare forms of inherited disease through to major causes of ill health over the life course and in ageing. It will be a crucial bridge between our world leading academic research and the needs of the NHS.

Professor David PorteousDirector of the Genetics Core at the Edinburgh Wellcome Trust Clinical Research Facility and of Systems Medicine at the MRC / University of Edinburgh Institute of Genetics and Molecular Medicine

 

We appreciate this great opportunity to bring our extensive genomics experience in this collaboration. I believe we could make more scientific breakthroughs in human health, animal science and evolution as well as other innovative research fields.

Ning LiDirector of BGI Europe

 

For more information contact:

Professor Mark Blaxter

  • School of Biological Sciences

Contact details

 

Tara Womersley

Contact details

 

Bicheng Yang

Branding and Communication Division

  • BGI

Contact details